Impfen Pro & Contra - Das Handbuch für die individuelle Impfentscheidung

studies. Pediatrics 2007, 120 (5): e1269–1277
    Baxter, D.: Vaccine responsiveness in premature infants. Hum Vaccin 2010, 6 (6): 506–511
    Bell, F., et al.: Adverse effects and sero-responses to an acellular pertussis/diphtheria/tetanus vaccine when combined with Haemophilus influenzae type b vaccine in an accelerated schedule. Eur J Pediatr 1999, 158 (4): 329–236H
    Bernsen, R. M., Nagelkerke, N. J., Thijs, C., van der Wouden, J. C.: Reported pertussis infection and risk of atopy in 8- to 12-yr-old vaccinated and nonvaccinated children. Pediatr Allergy Immunol 2008, 19 (1): 46–52
    BGM (Bundesministerium für Gesundheit ): Impfplan Österreich – Evidenz-basierte Empfehlungen des Obersten Sanitätsrates. 2011. http:// www.bmg.gv.at/cms/home/attachments/1/4/0/ CH 1100/ CMS 1038913010412/impfplan_2011.pdf (Zugriff 26. 11. 2011)
    Casey, J. R., Pichichero, M.: Acellular pertussis vaccine safety and efficacy in children, adolescents and adults. Drugs 2005, 65 (10): 1367–1389
    Castagnini, L. A., Healy, C. M., Rench, M. A., Wootton, S. H., et al.: Impact of Maternal Postpartum Tetanus and Diphtheria Toxoids and Acellular Pertussis Immunization on Infant Pertussis Infection. Clin Infect Dis 2011, 54 (1): 78–84
    CDC (Centers for Disease Control): Pertussis (Pink Book). 2007. http:// www.cdc.gov/vaccines/pubs/pinkbook/downloads/pert.pdf (Zugriff 2. 12. 2011)
    CDC (Centers for Disease Control): Pertussis – Outbreaks. 2011. http:// www.cdc.gov/pertussis/outbreaks.html (Zugriff 28. 11. 2011)
    Cherry, J. D., Gornbein, J., Heininger, U., Stehr, K.: A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 1998, 16 (20): 1901–1906
    Chiron Corporation: Chiron Biocine Genetically Engineered Acellular Pertussis Vaccine Proves Superior To Currently Licensed Vaccine. Chiron Press Release 13.7.1995. http://findarticles.com/p/articles/mi_m0 EIN /is_1995_July_13/ai_17247344/ (Zugriff 14.12.2011)
    David, S., Vermeer-de Bondt, P. E., van der Maas, N. A.: Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands. Vaccine 2008, 26 (46): 5883–5887
    De Greef, S. C., Schellekens, J. P. F., Mooi, F. R., de Melker, H. E.: Pertussis in the Netherlands 2001–2002. RIVM report 128507010, 2003. http:// www.rivm.nl/bibliotheek/rapporten/128507010.html (Zugriff 2. 12. 2011)
    DuVernoy, T. S., Braun, M. M.: Hypotonic-hyporesponsive episodes reported to the Vaccine Adverse Event Reporting System ( VAERS ), 1996–1998. Pediatrics 2000, 106 (4): E52
    EB (Epidemiologisches Bulletin): Zur Situation bei wichtigen Infektionskrankheiten. EB 1999, 19 (99): 119–141
    EB (Epidemiologisches Bulletin): Fragen und Antworten zu verschiedenen Impfungen. EB 2001 (8): 58f.
    EB (Epidemiologisches Bulletin): Zusätzliche Pertussis-Impfung im Erwachsenenalter als Tdap-Kombinationsimpfung bei der nächsten fälligen Td-Impfung – Empfehlung und Begründung. EB 2009, 31: 299–311, Anhang 1: http://edoc.rki.de/documents/rki_fv/re IT strUwm7D2/ PDF /28Tkr RL swXhvg02.pdf (Zugriff 30.11.2011)
    Ehrengut, W.: Über konvulsive Reaktionen nach Pertussis-Schutzimpfung. Dtsch Med Wschr 1974, 99: 2273–2279
    Esposito, S., Agliardi, T., Giammanco, A., et al.: Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection. Infect Immun 2001, 69 (7): 4516–4520
    Forsyth, K. D., Campins-Marti, M., Caro, J., Cherry, J. D.: New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative. Clin Infect Dis 2004, 39 (12): 1802–1809, http://cid.oxfordjournals.org/content/39/12/1802.full.pdf (Zugriff 30.11.2011)
    Galanis, E., King, A. S., Varughese, P., Halperin, S.A.: Changing epidemiology and emerging risk groups for pertussis. CMAJ 2006, 174 (4): 451–452
    GBE (Gesundheitsberichterstattung des Bundes) 2002. http:// www.gbe-bund.de/
    Geier, D. A., Geier, M. R.: An evaluation of serious neurological disorders following immunization: a comparison of whole-cell pertussis and acellular pertussis vaccines. Brain Dev 2004, 26 (5): 296–300
    Gustafsson, L., Hessel, L., Storsaeter, J., Olin, P.: Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age